EGFR and neoplasm: Seventy-one tumor-specific somatic mutations among 16 genes in 38 FFPE samples were identified, including genes with recurrent somatic alterations, such as TP53 (58.49%), PIK3CA (16.98%), EGFR (7.55%), PTCH1 (5.66%).